retatrutide trials in boston biotech secures Series A funding to move its once-weekly GLP-1 obesity patch into first-in-human clinical trials. ㅤ Link bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech retatrutide trials in boston Retatrutide

These findings suggest that the benefits of GLP-1 medications may extend well beyond weight loss alone

This is particularly relevant for oral contraceptives and medicines with a narrow therapeutic index

for peptides with lower oral stability, the ingested fraction contributes less

Another notable transcript upregulated in the -1 subcluster in response to liraglutide treatment was somatostatin ( SST ) (Figure 4B)

But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea

Average: 1 pound a week